Anti-B - India CDSCO Medical Device Registration

Anti-B is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000792_e1c2cf02a3f60908af6dbcf2273a1dc9_51439bc6a29e74a5888d14268c941a0e. This device is marketed under the brand name NOVACLONE Anti-A Murine Monoclonal. The license holder is Immucor India Pvt. Ltd.,, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Anti-B

UID: IMP/IVD/2020/000792_e1c2cf02a3f60908af6dbcf2273a1dc9_51439bc6a29e74a5888d14268c941a0e

Brand Name

NOVACLONE Anti-A Murine Monoclonal

License Holder

Immucor India Pvt. Ltd.,

Device Class

Class D

Approving Authority

CDSCO

Product Information

NOVACLONE Anti-B Murine Monoclonal provides a specific qualitative test for the detection of human blood group antigen – B. The test used with these Blood Grouping Reagents is based on the principle of direct hemagglutination. Incubation of test red cells with NOVACLONE™ Anti-A, Anti-B or Anti-A